The production had been stopped for at least four months, since there were “incidents of indiscipline”, making it difficult to continue operations peacefully, a Pfizer spokesperson said.
The plant was the only manufacturing unit of Pfizer in India. It employs 212.
Also Read
The executive said it had made arrangements, including contract manufacturing of products and import arrangements, for the domestic market.
The management has not indicated any timeline for starting operations.
The company said, “We are not in a position to resume operations till we are assured by the workmen the safety of our colleagues would not be compromised in any manner and the workmen will not indulge in acts of indiscipline.”
Pfizer has annual turnover of Rs 948 crore in India. It sells leading brands such as Corex and Becosules in the domestic market. It is a major presenceyer in the anti-diabetes segment and is significantly present in anti-infectives, cardiovascular and respiratory drugs.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)